• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传帕金森病中的多巴胺能神经元成像:发病机制的新见解。

Dopaminergic neuronal imaging in genetic Parkinson's disease: insights into pathogenesis.

机构信息

Department of Clinical Neurosciences, Institute of Neurology, University College London, London, United Kingdom.

出版信息

PLoS One. 2013 Jul 23;8(7):e69190. doi: 10.1371/journal.pone.0069190. Print 2013.

DOI:10.1371/journal.pone.0069190
PMID:23935950
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3720622/
Abstract

OBJECTIVES

To compare the dopaminergic neuronal imaging features of different subtypes of genetic Parkinson's Disease.

METHODS

A retrospective study of genetic Parkinson's diseases cases in which DaTSCAN (123I-FP-CIT) had been performed. Specific non-displaceable binding was calculated for bilateral caudate and putamen for each case. The right:left asymmetry index and striatal asymmetry index was calculated.

RESULTS

Scans were available from 37 cases of monogenetic Parkinson's disease (7 glucocerebrosidase (GBA) mutations, 8 alpha-synuclein, 3 LRRK2, 7 PINK1, 12 Parkin). The asymmetry of radioligand uptake for Parkinson's disease with GBA or LRRK2 mutations was greater than that for Parkinson's disease with alpha synuclein, PINK1 or Parkin mutations.

CONCLUSIONS

The asymmetry of radioligand uptake in Parkinsons disease associated with GBA or LRRK2 mutations suggests that interactions with additional genetic or environmental factors may be associated with dopaminergic neuronal loss.

摘要

目的

比较不同遗传型帕金森病亚型的多巴胺能神经元成像特征。

方法

对已行 DaTSCAN(123I-FP-CIT)检查的遗传型帕金森病病例进行回顾性研究。为每个病例计算双侧尾状核和壳核的特定非置换性结合。计算右侧/左侧不对称指数和纹状体不对称指数。

结果

共获得 37 例单基因帕金森病(7 例葡萄糖脑苷脂酶(GBA)突变,8 例α-突触核蛋白,3 例 LRRK2,7 例 PINK1,12 例 Parkin)的扫描结果。GBA 或 LRRK2 突变相关帕金森病的放射性配体摄取不对称性大于α-突触核蛋白、PINK1 或 Parkin 突变相关帕金森病。

结论

与 GBA 或 LRRK2 突变相关帕金森病的放射性配体摄取不对称性表明,与其他遗传或环境因素的相互作用可能与多巴胺能神经元丢失有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1475/3720622/a208a65b832a/pone.0069190.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1475/3720622/22efbb2bfa43/pone.0069190.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1475/3720622/1358bda3da5d/pone.0069190.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1475/3720622/a208a65b832a/pone.0069190.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1475/3720622/22efbb2bfa43/pone.0069190.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1475/3720622/1358bda3da5d/pone.0069190.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1475/3720622/a208a65b832a/pone.0069190.g003.jpg

相似文献

1
Dopaminergic neuronal imaging in genetic Parkinson's disease: insights into pathogenesis.遗传帕金森病中的多巴胺能神经元成像:发病机制的新见解。
PLoS One. 2013 Jul 23;8(7):e69190. doi: 10.1371/journal.pone.0069190. Print 2013.
2
Onset-related subtypes of Parkinson's disease differ in the patterns of striatal dopaminergic dysfunction: A positron emission tomography study.帕金森病起病相关亚型在纹状体多巴胺能功能障碍模式上存在差异:一项正电子发射断层扫描研究。
Parkinsonism Relat Disord. 2015 Dec;21(12):1448-53. doi: 10.1016/j.parkreldis.2015.10.017. Epub 2015 Oct 30.
3
[123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease.[123I]FP - CIT单光子发射计算机断层扫描显示,在早期和晚期帕金森病中,纹状体多巴胺转运体标记明显减少。
J Neurol Neurosurg Psychiatry. 1997 Feb;62(2):133-40. doi: 10.1136/jnnp.62.2.133.
4
DaTSCAN (123I-FP-CIT SPECT) imaging in early versus mid and late onset Parkinson's disease: Longitudinal data from the PPMI study.DaTSCAN(123I-FP-CIT SPECT)成像在早发性与中晚期帕金森病中的对比:来自 PPMI 研究的纵向数据。
Parkinsonism Relat Disord. 2020 Aug;77:36-42. doi: 10.1016/j.parkreldis.2020.06.019. Epub 2020 Jun 22.
5
Pallidal dopaminergic denervation and rest tremor in early Parkinson's disease: PPMI cohort analysis.苍白球多巴胺能神经末梢变性与早期帕金森病的静止性震颤:PPMI 队列分析。
Parkinsonism Relat Disord. 2018 Jun;51:101-104. doi: 10.1016/j.parkreldis.2018.02.039. Epub 2018 Feb 24.
6
Weight loss is associated with rapid striatal dopaminergic degeneration in Parkinson's disease.体重减轻与帕金森病中纹状体多巴胺能快速退化有关。
Parkinsonism Relat Disord. 2018 Jun;51:67-72. doi: 10.1016/j.parkreldis.2018.02.044. Epub 2018 Feb 28.
7
123I-FP-CIT SPECT [(123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography] Imaging in a p.A53T α-synuclein Parkinson's disease cohort versus Parkinson's disease.123I-FP-CIT SPECT(123 碘-2β- 碳甲氧基-3β-(4- 碘苯基)-N-(3- 氟丙基)去甲托烷单光子发射计算机断层扫描)成像在帕金森病患者与帕金森病患者的 p.A53T α- 突触核蛋白帕金森病队列中的应用。
Mov Disord. 2018 Nov;33(11):1734-1739. doi: 10.1002/mds.27451. Epub 2018 Oct 4.
8
123I-FP-CIT semi-quantitative SPECT detects preclinical bilateral dopaminergic deficit in early Parkinson's disease with unilateral symptoms.123I - FP - CIT半定量单光子发射计算机断层扫描(SPECT)可检测出有单侧症状的早期帕金森病患者临床上未出现的双侧多巴胺能缺陷。
Nucl Med Commun. 2005 May;26(5):421-6. doi: 10.1097/00006231-200505000-00005.
9
Dual-phase F-FP-CIT positron emission tomography and cardiac I-MIBG scintigraphy of Parkinson's disease patients with GBA mutations: evidence of the body-first type?携带GBA突变的帕金森病患者的双相F-FP-CIT正电子发射断层扫描和心脏I-MIBG闪烁扫描:身体优先型的证据?
Eur J Neurol. 2023 Feb;30(2):344-352. doi: 10.1111/ene.15615. Epub 2022 Nov 16.
10
Precise Evaluation of Striatal Oxidative Stress Corrected for Severity of Dopaminergic Neuronal Degeneration in Patients with Parkinson's Disease: A Study with 62Cu-ATSM PET and 123I-FP-CIT SPECT.帕金森病患者纹状体氧化应激的精确评估:校正多巴胺能神经元变性严重程度后的研究,采用62Cu-ATSM正电子发射断层扫描(PET)和123I-FP-CIT单光子发射计算机断层扫描(SPECT)。
Eur Neurol. 2017;78(3-4):161-168. doi: 10.1159/000479627. Epub 2017 Aug 24.

引用本文的文献

1
Association of Hemispheric Asymmetry of Dopamine-Transporter Binding with Risk of Parkinsonian Depression.多巴胺转运体结合半球不对称与帕金森病性抑郁风险的关联
Mov Disord Clin Pract. 2025 Mar;12(3):302-312. doi: 10.1002/mdc3.14276. Epub 2024 Nov 20.
2
Imaging Markers in Genetic Forms of Parkinson's Disease.帕金森病遗传形式中的影像学标志物。
Brain Sci. 2023 Aug 16;13(8):1212. doi: 10.3390/brainsci13081212.
3
GBA1 Variants and Parkinson's Disease: Paving the Way for Targeted Therapy.GBA1基因变异与帕金森病:为靶向治疗铺平道路。

本文引用的文献

1
Interplay of LRRK2 with chaperone-mediated autophagy.LRRK2 与伴侣蛋白介导的自噬相互作用。
Nat Neurosci. 2013 Apr;16(4):394-406. doi: 10.1038/nn.3350. Epub 2013 Mar 3.
2
Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains.帕金森病脑黑质中葡萄糖脑苷脂酶缺乏。
Ann Neurol. 2012 Sep;72(3):455-63. doi: 10.1002/ana.23614.
3
FDG-PET and molecular brain imaging in the movement disorders clinic.运动障碍门诊中的氟代脱氧葡萄糖正电子发射断层扫描(FDG-PET)与分子脑成像
J Mov Disord. 2023 Sep;16(3):261-278. doi: 10.14802/jmd.23023. Epub 2023 Jun 12.
4
Quantitative dopamine transporter imaging assessment in Parkinson's disease patients carrying GBA gene mutations compared with idiopathic PD patients: A case-control study.帕金森病患者携带 GBA 基因突变与特发性 PD 患者的定量多巴胺转运体成像评估:一项病例对照研究。
Brain Behav. 2023 Jul;13(7):e3060. doi: 10.1002/brb3.3060. Epub 2023 Jun 1.
5
Neuroimaging in Glucocerebrosidase-Associated Parkinsonism: A Systematic Review.神经影像学在葡萄糖脑苷脂酶相关性帕金森病中的应用:系统综述。
Mov Disord. 2022 Jul;37(7):1375-1393. doi: 10.1002/mds.29047. Epub 2022 May 6.
6
Subthalamic Peak Beta Ratio Is Asymmetric in Glucocerebrosidase Mutation Carriers With Parkinson's Disease: A Pilot Study.帕金森病伴葡萄糖脑苷脂酶突变携带者的丘脑底核峰值β比值不对称:一项初步研究。
Front Neurol. 2021 Sep 30;12:723476. doi: 10.3389/fneur.2021.723476. eCollection 2021.
7
Dancing Feet Dyskinesia in a Patient with GBA-PD.一名GBA-PD患者出现的舞蹈足运动障碍
J Mov Disord. 2022 Jan;15(1):83-85. doi: 10.14802/jmd.20169. Epub 2021 May 3.
8
Cross-talks among GBA mutations, glucocerebrosidase, and α-synuclein in GBA-associated Parkinson's disease and their targeted therapeutic approaches: a comprehensive review.GBA 突变、葡萄糖脑苷脂酶和α-突触核蛋白在 GBA 相关帕金森病中的相互作用及其靶向治疗方法:综述。
Transl Neurodegener. 2021 Jan 15;10(1):4. doi: 10.1186/s40035-020-00226-x.
9
Brain Microglial Activation Increased in Glucocerebrosidase (GBA) Mutation Carriers without Parkinson's disease.脑微胶质细胞活化在帕金森病 GBA 基因突变携带者中增加。
Mov Disord. 2021 Mar;36(3):774-779. doi: 10.1002/mds.28375. Epub 2020 Dec 5.
10
Novel PET Biomarkers to Disentangle Molecular Pathways across Age-Related Neurodegenerative Diseases.新型 PET 生物标志物可厘清与年龄相关的神经退行性疾病中的分子途径。
Cells. 2020 Dec 2;9(12):2581. doi: 10.3390/cells9122581.
Neurology. 2012 Sep 25;79(13):1306-7. doi: 10.1212/WNL.0b013e31826c1be1. Epub 2012 Aug 22.
4
The genetics and neuropathology of Parkinson's disease.帕金森病的遗传学和神经病理学。
Acta Neuropathol. 2012 Sep;124(3):325-38. doi: 10.1007/s00401-012-1013-5. Epub 2012 Jul 18.
5
A clinical and family history study of Parkinson's disease in heterozygous glucocerebrosidase mutation carriers.杂合性葡萄糖脑苷脂酶突变携带者帕金森病的临床及家族史研究
J Neurol Neurosurg Psychiatry. 2012 Aug;83(8):853-4. doi: 10.1136/jnnp-2012-302402. Epub 2012 May 10.
6
Considerations regarding the etiology and future treatment of autosomal recessive versus idiopathic Parkinson disease.探讨常染色体隐性遗传与特发性帕金森病的病因和未来治疗方法。
Curr Treat Options Neurol. 2012 Jun;14(3):230-40. doi: 10.1007/s11940-012-0175-8.
7
Aggregation of α-synuclein is kinetically controlled by intramolecular diffusion.α-突触核蛋白的聚集受分子内扩散的动力学控制。
Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2336-41. doi: 10.1073/pnas.1109526109. Epub 2012 Jan 27.
8
Bioenergetic consequences of PINK1 mutations in Parkinson disease.帕金森病中 PINK1 突变的生物能量学后果。
PLoS One. 2011;6(10):e25622. doi: 10.1371/journal.pone.0025622. Epub 2011 Oct 17.
9
Parkinsonism associated with glucocerebrosidase mutation.帕金森病与葡萄糖脑苷脂酶突变相关。
J Clin Neurol. 2011 Jun;7(2):99-101. doi: 10.3988/jcn.2011.7.2.99. Epub 2011 Jun 28.
10
Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies.戈谢病葡萄糖脑苷脂酶和α-突触核蛋白在突触核蛋白病中形成一个双向致病环。
Cell. 2011 Jul 8;146(1):37-52. doi: 10.1016/j.cell.2011.06.001. Epub 2011 Jun 23.